TGIA, Inc.
Update：2026/08/06
Industries
Main Industry
Biotechnology
Main Product/Service
TGIA offers high-throughput next-generation and third-generation sequencing services in Taiwan, utilising industry-grade systems such as Illumina NovaSeq X Plus, NovaSeq 6000 and PacBio Sequel IIe.
Their service portfolio spans whole genome sequencing a
Their service portfolio spans whole genome sequencing a
Founded Year
2017
Unified Business No.
52608581
Status
Active
Number of Employees
0
Total Paid-in
Capital
192,432,060 (NT$)
Location of Company
Taiwan
, Hsinchu County
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Taiwan Genomic Industry Alliance Inc. (TGIA) is a Taiwan-based company located in Nankang Software Park and, since 2022, headquartered in Hsinchu Biomedical Science Park as its operational and R&D center. Established under the guidance of the “Asia Pacific Biomedical Silicon Valley Precision Medicine Program” operated by the National Health Research Institutes (NHRI) in 2017, TGIA collaborates with NHRI through technology transfer to become a leading player in disease, genetics and cancer-genetics sequencing, serving as an important medical hub in the Asia-Pacific region
